Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.10B | 4.45B | 4.58B | 4.01B | 3.95B |
Gross Profit | 1.18B | 1.28B | 1.37B | 1.14B | 1.09B |
EBITDA | 400.70M | 464.40M | 500.90M | 440.50M | 370.90M |
Net Income | 175.20M | 219.30M | 268.10M | 231.80M | 200.30M |
Balance Sheet | |||||
Total Assets | 3.43B | 3.54B | 3.59B | 3.50B | 3.28B |
Cash, Cash Equivalents and Short-Term Investments | 205.20M | 175.90M | 70.30M | 529.60M | 274.40M |
Total Debt | 1.10B | 1.11B | 1.12B | 1.10B | 1.13B |
Total Liabilities | 1.65B | 1.65B | 1.68B | 1.64B | 1.69B |
Stockholders Equity | 1.78B | 1.89B | 1.90B | 1.87B | 1.59B |
Cash Flow | |||||
Free Cash Flow | 364.70M | 417.00M | 270.30M | 159.00M | 392.20M |
Operating Cash Flow | 400.00M | 456.90M | 307.80M | 193.70M | 424.80M |
Investing Cash Flow | -35.30M | -40.50M | -510.00M | 246.50M | -219.00M |
Financing Cash Flow | -333.20M | -310.90M | -256.50M | -184.40M | -29.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $3.21B | 20.01 | 21.23% | ― | 1.94% | 26.15% | |
76 Outperform | $8.87B | 22.71 | 11.36% | ― | 9.73% | -0.29% | |
72 Outperform | $6.92B | 29.31 | 24.70% | ― | 15.15% | 34.33% | |
70 Outperform | $3.08B | 13.41 | 5.59% | 2.76% | 11.31% | -16.02% | |
69 Neutral | $2.22B | 16.44 | 7.71% | ― | -6.31% | -23.56% | |
68 Neutral | $2.47B | 6.68 | 12.60% | ― | -4.93% | 497.03% | |
61 Neutral | $36.30B | 7.30 | -7.27% | 1.97% | 7.76% | -6.42% |
On July 31, 2025, ASGN Incorporated entered into a Second Amendment to its Third Amended and Restated Credit Agreement, introducing an incremental term loan facility of $100 million. This amendment aims to enhance ASGN’s financial flexibility, allowing for strategic allocation of cash flows towards organic business investments, future acquisitions, and share buybacks.
The most recent analyst rating on (ASGN) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on ASGN stock, see the ASGN Stock Forecast page.
At the 2025 Annual Meeting of Stockholders held on June 12, 2025, ASGN Incorporated’s stockholders approved amendments to the company’s 2010 Incentive Award Plan and Employee Stock Purchase Plan. The meeting also saw the election of four directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (ASGN) stock is a Hold with a $101.00 price target. To see the full list of analyst forecasts on ASGN stock, see the ASGN Stock Forecast page.